Biogen Inc (BIIB)
Cash conversion cycle
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 175.04 | 178.76 | 171.57 | 170.11 | 166.44 | 200.35 | 98.18 | 95.23 | 96.99 | 84.61 | 78.09 | 73.70 | 87.07 | 128.57 | 147.27 | 176.45 | 216.06 | 212.94 | 199.56 | 173.40 |
Days of sales outstanding (DSO) | days | 52.99 | — | — | — | 61.75 | — | — | 59.04 | 61.17 | 55.25 | 53.81 | 55.06 | 51.50 | 56.65 | 52.67 | 53.70 | 51.96 | 51.82 | 53.75 | 52.96 |
Number of days of payables | days | 30.18 | 30.60 | 24.27 | 26.16 | 26.56 | 29.57 | 32.79 | 36.52 | 35.46 | 23.58 | 26.23 | 24.18 | 37.96 | 40.81 | 44.05 | 64.81 | 91.98 | 82.55 | 80.42 | 78.54 |
Cash conversion cycle | days | 197.85 | 148.16 | 147.30 | 143.95 | 201.64 | 170.79 | 65.38 | 117.75 | 122.70 | 116.28 | 105.66 | 104.58 | 100.61 | 144.41 | 155.89 | 165.34 | 176.04 | 182.21 | 172.90 | 147.82 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 175.04 + 52.99 – 30.18
= 197.85
Biogen Inc's cash conversion cycle, which represents the time it takes for the company to convert its investments in inventory and other resources into cash flows from sales, has exhibited fluctuations over the period from March 31, 2020, to December 31, 2024.
The company's cash conversion cycle ranged from a high of 201.64 days on December 31, 2023, to a low of 65.38 days on June 30, 2023. During this period, there were peaks and valleys in the cycle, indicating potential challenges with managing inventory, accounts receivable, and accounts payable efficiently.
A higher cash conversion cycle suggests that the company is holding onto inventory or receivables for a longer period, which could tie up capital and impact liquidity. Conversely, a lower cycle indicates faster conversion of resources into cash, which can enhance the company's working capital management.
Overall, Biogen Inc should aim to monitor its cash conversion cycle closely and implement strategies to optimize inventory levels, streamline accounts receivable collections, and manage accounts payables effectively to improve cash flow and operational efficiency.
Peer comparison
Dec 31, 2024